Chefaa raises $5.25 million to simplify the prescription ordering process

🏥 Here's Chefaa! The Egypt-based e-pharmacy benefits platform that helps chronic patients order, schedule, and refill recurring prescriptions.

And guess what? They've just secured $5.25 million in their latest series A funding round!

• Founded in 2017 by Dr. Doaa Aref and Dr. Rasha Rady, the healthtech start-up connects over a million monthly users to more than 1,100 pharmacies across Egypt & KSA.

💰 Investor lowdown: This funding round was co-led by Newtown Partners (South Africa) and Global Brain (Japan), with key contributions from GMS Capital Partners LLC (US), Verod-Kepple Africa Ventures (Nigeria), and M3, Inc. (Japan).

🏃 Healthcare hurdle

Despite technological advances, many in the GCC and SSA regions still face hurdles in accessing timely and reliable healthcare services. 

Addressing this challenge involves more than just availability; it's about tailoring healthcare to meet the varied requirements of both patients and providers effectively.

🌉 Bridging the gap

Chefaa's digital platform bridges the gap between users and a vast network of local pharmacies, ensuring easy access to medications and healthcare resources.

Their mobile app, with over 800,000 downloads, simplifies the process of ordering, scheduling, and refilling prescriptions, making it a hassle-free experience for users.

The platform not only guarantees efficient delivery of medicines and healthcare services but also offers transparent tracking through the app, enhancing the user experience.

Additionally, their round-the-clock "Ask Pharmacist" service provides dependable support, ensuring patients always receive the correct medication or appropriate alternatives when needed.

🔮 Flashforward

Having recently expanded into Saudi Arabia, Chefaa intends to utilise its new funding to strengthen its presence in the kingdom and scale up its models aimed at digitising the supply chain.